Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2850 of 3173 entries
View as:

A Study to Learn How Different Forms of Study Medicine Tafamidis Are Taken Up Into The Blood in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06273839 Org: User:
Start: 02/27/24 End: 05/27/24 Due: 05/27/25

A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS

Phase: N/A Priority: Normal
NCT ID: NCT00002282 Org: User:
Start: - End: - Due: -

Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT00707239 Org: User:
Start: 12/31/08 End: 06/30/11 Due: 06/30/12

A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00074854 Org: User:
Start: 05/31/02 End: 03/31/05 Due: 03/31/06

Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan

Phase: N/A Priority: Normal
NCT ID: NCT00150332 Org: User:
Start: 01/31/03 End: 01/31/06 Due: 01/31/07

A Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03049423 In Healthy Adult Volunteers And Healthy Older Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01161069 Org: User:
Start: 08/31/09 End: 12/31/09 Due: 12/31/10

Figitumumab Combined With Pegvisomant For Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00976508 Org: User:
Start: 11/30/09 End: 10/31/12 Due: 10/31/13

Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01029405 Org: User:
Start: 11/30/09 End: 06/30/10 Due: 06/30/11

Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis

Phase: N/A Priority: Normal
NCT ID: NCT03010228 Org: User:
Start: 01/31/17 End: 01/16/19 Due: 01/16/20

A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01677065 Org: User:
Start: 09/30/12 End: 10/31/12 Due: 10/31/13

A Study to Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 and How Much Money People Spend on Healthcare for COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT06923137 Org: User:
Start: 04/16/25 End: 10/31/30 Due: 10/31/31

Prospective Evaluation of the Radiographic Efficacy of Enbrel

Phase: N/A Priority: Normal
NCT ID: NCT01623752 Org: User:
Start: 02/29/12 End: 03/31/18 Due: 03/31/19

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

Phase: N/A Priority: Normal
NCT ID: NCT06551324 Org: User:
Start: 10/21/24 End: 10/29/28 Due: 10/29/29

Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

Phase: N/A Priority: Normal
NCT ID: NCT05509400 Org: User:
Start: 10/18/22 End: 06/21/25 Due: 06/21/26

OPEN LABEL, 2-PERIOD STUDY, TO COMPARE BIO-AVAILABILITY OF 2 DIFFERENT FORMULATIONS OF PF-05221304 IN HEALTHY ADULTS

Phase: N/A Priority: Normal
NCT ID: NCT03871439 Org: User:
Start: 03/13/19 End: 05/08/19 Due: 05/08/20

Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants

Phase: N/A Priority: Normal
NCT ID: NCT01200368 Org: User:
Start: 09/24/10 End: 11/30/11 Due: 11/30/12

Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00683800 Org: User:
Start: 06/30/08 End: 05/31/10 Due: 05/31/11

Study of Different Doses of a Novel Treatment for Onychomycosis

Phase: N/A Priority: Normal
NCT ID: NCT00679770 Org: User:
Start: 06/30/06 End: 08/31/07 Due: 08/31/08

Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause

Phase: N/A Priority: Normal
NCT ID: NCT00314964 Org: User:
Start: 08/31/06 End: 07/31/07 Due: 07/31/08

A Study To Evaluate D1 Receptor Occupancy (RO) Following Single Dose of PF-06412562 In Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02124213 Org: User:
Start: 09/30/14 End: 10/31/14 Due: 10/31/15

A Study Of The Effect Of CJ-023,423 On The Incidence Of Stomach Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00392080 Org: User:
Start: 11/30/06 End: 02/29/08 Due: 02/28/09

Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey

Phase: N/A Priority: Normal
NCT ID: NCT01810861 Org: User:
Start: 01/04/13 End: 07/31/19 Due: 07/31/20

PF-00489791 For The Treatment Of Raynaud's

Phase: N/A Priority: Normal
NCT ID: NCT01090492 Org: User:
Start: 08/04/10 End: 05/31/11 Due: 05/31/12

Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.

Phase: N/A Priority: Normal
NCT ID: NCT00319501 Org: User:
Start: 01/31/06 End: 07/31/14 Due: 07/31/15

Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide

Phase: N/A Priority: Normal
NCT ID: NCT00796159 Org: User:
Start: 07/31/07 End: 12/31/08 Due: 12/31/09